Effects of 12-month physical and cognitive training on sarcopenia determinants in older adults: a subgroup analysis of a randomised clinical trial
Aging Clinical and Experimental Research · 2025
DOI: 10.1007/s40520-025-02935-7 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Aging Clinical and Experimental Research, 2025. Verfasst von Onni Oskari Hämäläinen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Sport and Health Science, University of Jyväskylä, Jyväskylä, Finland. onni.o.hamalainen@jyu.fi. Hauptthemen laut MEDLINE: Sarcopenia, Exercise, Exercise Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Jyväskylä.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Low physical activity is a major risk for sarcopenia. Whether training according to physical activity guidelines accompanied with cognitive training is effective on sarcopenia, remains unclear.
Aims
We investigated whether the effects of 12-month physical and cognitive training (PTCT) and physical training (PT) on grip and knee extension strength, muscle mass, and walking speed differed between older adults with and without sarcopenia.
Methods
Community-dwelling older adults ( N = 314, mean age 74.5 ± 3.8 years, 60% women) who did not meet physical activity guidelines were randomized to PTCT and PT groups. PT for both groups included supervised and home-based multicomponent physical training. Cognitive training (CT) included computer-based exercises for executive functioning. Sarcopenia was determined according to the European Working Group on Sarcopenia in Older People 2019 criteria. Generalized estimation equation analysis were conducted.
Results
Compared to PT, PTCT had no additive effect on strength, muscle mass, or walking speed in participants with or without sarcopenia. In pooled data (PT + PTCT) change in the grip strength was greater in sarcopenia ( n = 49) group compared to non-sarcopenia ( n = 264) group (interaction, p =.014). Both groups improved knee extension strength, and walking speed, but no statistically significant difference between the groups were observed. Muscle mass did not change in either group.
Conclusion
Physical training according to physical activity recommendations improves muscle strength, walking speed, and maintains muscle mass in sarcopenia. Additional cognitive training had no benefits on these outcomes. Trial registration number ISRCTN52388040 and date of registration 20/1/2017.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Sport and Health Science, University of Jyväskylä, Jyväskylä, Finland. onni.o.hamalainen@jyu.fi.
- Gerontology Research Center, University of Jyväskylä, Jyväskylä, Finland. onni.o.hamalainen@jyu.fi.
- Faculty of Sport and Health Science, University of Jyväskylä, Jyväskylä, Finland.
- Gerontology Research Center, University of Jyväskylä, Jyväskylä, Finland.
- Department of Medical Rehabilitation, Oulu University Hospital, Oulu, Finland.
Förderung
- University of Jyväskylä
Zitieren
APA
Hämäläinen, O. O., Savikangas, T. M., Tirkkonen, A. K., Alén, M. J., Hautala, A. J., & Sipilä, S. (2025). Effects of 12-month physical and cognitive training on sarcopenia determinants in older adults: a subgroup analysis of a randomised clinical trial. Aging Clinical and Experimental Research. https://doi.org/10.1007/s40520-025-02935-7
Vancouver
Hämäläinen OO, Savikangas TM, Tirkkonen AK, Alén MJ, Hautala AJ, Sipilä S. Effects of 12-month physical and cognitive training on sarcopenia determinants in older adults: a subgroup analysis of a randomised clinical trial. Aging Clinical and Experimental Research. 2025. doi:10.1007/s40520-025-02935-7
BibTeX
@article{Hmlinen2025,
author = {Hämäläinen, Onni Oskari and Savikangas, Tiina Marketta and Tirkkonen, Anna-Katriina and Alén, Markku Juhani and Hautala, Arto Jorma and Sipilä, Sarianna},
title = {Effects of 12-month physical and cognitive training on sarcopenia determinants in older adults: a subgroup analysis of a randomised clinical trial},
journal = {Aging Clinical and Experimental Research},
year = {2025},
doi = {10.1007/s40520-025-02935-7}
}
EUVIMED